Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Symrise To Buy Probiotics Maker

by Marc S. Reisch
January 20, 2014 | A version of this story appeared in Volume 92, Issue 3

Symrise has increased its shareholding in Swedish probiotics maker Probi to more than 30% of shares outstanding. Under Swedish securities law, the German maker of flavors, fragrances, and health ingredients is now required to make a public offer for the 70% of Probi it doesn’t own at a price of $6.46 per share, or $40.6 million. The price corresponds to the highest price Symrise paid for Probi shares in the past six months. Symrise became Probi’s largest shareholder in August 2012. The two signed a joint research agreement in December 2012 initially focused on oral-health applications.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.